Allied delivers a variety of cannabis formulations for health and wellness applications. Depression, Anxiety and PTSD are Allied’s priority. With extensive expertise in medical discovery and research, cannabis cultivation and processing, proprietary products and natural health product distribution, we are fully integrated across the value chain.
We are unique in our ‘full scope’ approach to cannabinoid product development. The global cannabis market is expected to grow from $11bn to $56bn by 2025. South America is positioned to become the new global supply source as global demand will outstrip supply. Allied is ready.
We also have a purposeful strategy to be in line for US legalization. While we grow each of Allied’s business segment to realize revenue, Allied will continue to expand upon emerging scientific discoveries in new markets.
Low Cost, High Quality, High Margin
Low cost of production – $0.09-0.15 per gram of dry flower vs average of $1.52/ gram in Canada. Low-cost, high-margin model.
Experienced Management Team
Decades of production and extraction expertise. Strong regional and agricultural specialists in each country. Experienced business support team active in market support and production execution.
Our mission is to help people around the world by creating and providing targeted cannabinoid health solutions using pharmaceutical R&D, innovative plant-based production, and unique development of therapeutic products.
Our operations span from a large production center in South America to R&D of targeted cannabinoid health solutions in Canada for today’s medical issues. Our end-to-end business model enables Allied to bring unique products to market.
Allied Charitable Activities
Our charitable based activities support many organizations around the globe. In-person healing retreats, supportive athletic events and connection to a peer-community provide on-going support for veterans, police, fire, and emergency health first-responders.